BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,321,381 | -17.5% | 114,504 | -0.4% | 0.02% | -13.0% |
| Q2 2023 | $5,237,942 | -13.4% | 114,968 | -22.9% | 0.02% | -11.5% |
| Q1 2023 | $6,050,214 | -26.5% | 149,167 | -7.6% | 0.03% | -27.8% |
| Q4 2022 | $8,231,706 | -8.6% | 161,501 | -3.5% | 0.04% | -14.3% |
| Q3 2022 | $9,009,000 | -16.0% | 167,274 | +0.2% | 0.04% | -8.7% |
| Q2 2022 | $10,722,000 | -47.7% | 166,926 | -36.9% | 0.05% | -38.7% |
| Q1 2022 | $20,500,000 | +44.0% | 264,378 | +59.4% | 0.08% | +50.0% |
| Q4 2021 | $14,241,000 | +3.1% | 165,904 | -3.4% | 0.05% | -3.8% |
| Q3 2021 | $13,808,000 | -69.0% | 171,674 | -69.0% | 0.05% | -67.7% |
| Q2 2021 | $44,552,000 | -5.3% | 553,444 | -0.8% | 0.16% | -9.6% |
| Q1 2021 | $47,053,000 | +2.3% | 557,897 | -2.7% | 0.18% | -1.7% |
| Q4 2020 | $45,994,000 | -0.3% | 573,203 | -0.1% | 0.18% | -14.6% |
| Q3 2020 | $46,124,000 | -2.9% | 573,536 | +3.9% | 0.21% | -7.8% |
| Q2 2020 | $47,507,000 | +160.7% | 551,765 | +145.8% | 0.23% | +127.7% |
| Q1 2020 | $18,222,000 | -2.9% | 224,437 | +0.0% | 0.10% | +21.7% |
| Q4 2019 | $18,763,000 | -4.1% | 224,385 | +0.4% | 0.08% | -11.7% |
| Q3 2019 | $19,557,000 | +7.9% | 223,582 | +1.0% | 0.09% | +10.6% |
| Q2 2019 | $18,123,000 | -25.6% | 221,277 | -26.1% | 0.08% | -28.0% |
| Q1 2019 | $24,360,000 | +17.1% | 299,594 | -5.2% | 0.12% | +2.6% |
| Q4 2018 | $20,809,000 | -13.5% | 316,143 | +1.3% | 0.12% | +0.9% |
| Q3 2018 | $24,053,000 | +41.0% | 312,010 | +35.0% | 0.11% | +35.7% |
| Q2 2018 | $17,064,000 | +10.5% | 231,091 | -2.7% | 0.08% | +10.5% |
| Q1 2018 | $15,440,000 | -1.7% | 237,391 | -2.3% | 0.08% | 0.0% |
| Q4 2017 | $15,703,000 | -23.4% | 242,925 | -25.7% | 0.08% | -29.0% |
| Q3 2017 | $20,510,000 | +43.3% | 326,852 | +38.2% | 0.11% | +39.0% |
| Q2 2017 | $14,317,000 | +17.5% | 236,495 | +0.7% | 0.08% | +14.9% |
| Q1 2017 | $12,185,000 | +15.1% | 234,960 | -1.6% | 0.07% | +9.8% |
| Q4 2016 | $10,589,000 | -10.1% | 238,809 | -3.5% | 0.06% | -11.6% |
| Q3 2016 | $11,785,000 | -7.4% | 247,576 | -12.1% | 0.07% | -6.8% |
| Q2 2016 | $12,730,000 | -52.0% | 281,522 | -56.4% | 0.07% | -52.9% |
| Q1 2016 | $26,525,000 | +6.9% | 645,702 | -0.7% | 0.16% | +7.5% |
| Q4 2015 | $24,804,000 | +12.0% | 650,170 | -3.6% | 0.15% | +9.8% |
| Q3 2015 | $22,149,000 | -53.3% | 674,260 | -0.7% | 0.13% | -48.4% |
| Q2 2015 | $47,463,000 | +30.5% | 678,724 | +27.8% | 0.26% | +31.6% |
| Q1 2015 | $36,380,000 | -10.6% | 531,098 | -4.4% | 0.20% | -9.7% |
| Q4 2014 | $40,716,000 | +2.0% | 555,549 | -0.1% | 0.22% | -2.7% |
| Q3 2014 | $39,918,000 | +1.2% | 556,196 | +2.0% | 0.22% | +1.4% |
| Q2 2014 | $39,438,000 | -1.4% | 545,482 | +0.3% | 0.22% | -5.2% |
| Q1 2014 | $40,002,000 | -9.1% | 543,654 | -14.1% | 0.23% | -11.1% |
| Q4 2013 | $44,015,000 | +5.9% | 632,858 | +0.1% | 0.26% | -1.1% |
| Q3 2013 | $41,549,000 | -5.1% | 632,494 | +0.1% | 0.26% | -9.9% |
| Q2 2013 | $43,789,000 | -3.8% | 632,151 | +0.9% | 0.29% | -6.7% |
| Q1 2013 | $45,510,000 | – | 626,510 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |